Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-metastatic Patients With Rectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06967155
What this trial is testing

Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People With Metastatic Colorectal Cancer

Who this might be right for
Neoplasms
Blokhin's Russian Cancer Research Center 23
Large-scale testing (Phase 3)Looking for participantsNCT06275958
What this trial is testing

DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer

Who this might be right for
Older PatientsColorectal CancerMetastatic Cancer+1 more
Leiden University Medical Center 587
Testing effectiveness (Phase 2)Study completedNCT02743221
What this trial is testing

A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier 154
Not applicableStudy completedNCT06704646
What this trial is testing

Predictors of One-Year Mortality After Curative Surgery in Patients Aged 80 Years or Older With Non-Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Taiwan University Hospital 310
Early research (Phase 1)Study completedNCT04330664
What this trial is testing

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 86
Early research (Phase 1)Looking for participantsNCT04999761
What this trial is testing

AB122 Platform Study

Who this might be right for
Advanced or Metastatic Solid TumorPancreatic Ductal AdenocarcinomaColorectal Cancer+6 more
Taiho Pharmaceutical Co., Ltd. 917
Early research (Phase 1)Study completedNCT00934882
What this trial is testing

Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI

Who this might be right for
Colorectal Neoplasms
Bayer 45
Not applicableStudy completedNCT01310985
What this trial is testing

A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer

Who this might be right for
Colon Rectal Cancer Duke Stage Stageval
King Faisal Specialist Hospital & Research Center 15
Testing effectiveness (Phase 2)Study completedNCT00560560
What this trial is testing

Study Using CP-751,871 In Patients With Stage IV Colorectal Cancer That Has Not Responded To Previous Anti-Cancer Treatments

Who this might be right for
Colorectal Neoplasm
Pfizer 168
Testing effectiveness (Phase 2)Study completedNCT00109226
What this trial is testing

Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Genentech, Inc.
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Active Not RecruitingNCT05907304
What this trial is testing

Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations

Who this might be right for
Advanced or Metastatic Solid Tumors
Erasca, Inc. 86
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725
What this trial is testing

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00511862
What this trial is testing

TheraSphere for the Treatment of Liver Metastases

Who this might be right for
Colorectal CancerCarcinoma, NeuroendocrineNeoplasm Metastasis
Boston Scientific Corporation 151
Early research (Phase 1)Looking for participantsNCT07623369
What this trial is testing

A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Huahui Health 299
Testing effectiveness (Phase 2)UnknownNCT04695470
What this trial is testing

Phase II Trial of Fruquintinib With Sintilimab in Treating Selected Refractory Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
Aiping Zhou 70
Testing effectiveness (Phase 2)Ended earlyNCT00390364
What this trial is testing

Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy

Who this might be right for
Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Testing effectiveness (Phase 2)Study completedNCT00103311
What this trial is testing

SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IIIA Colon Cancer+9 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT02888743
What this trial is testing

Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Lung Non-Small Cell CarcinomaStage IV Colorectal Cancer AJCC v7+3 more
National Cancer Institute (NCI) 110
Early research (Phase 1)Study completedNCT00514007
What this trial is testing

Study of Continuous OSI-906 Dosing

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Next Page